Latest Market News

WA Kaolin Limited has announced a $34.9 million recapitalisation plan involving a non-renounceable entitlement issue and debt conversion to strengthen its balance sheet and fund operational improvements at its Wickepin kaolin project.

Insignia Financial has secured a crucial regulatory approval from APRA, advancing the proposed acquisition by Daintree BidCo. The deal now moves closer to a shareholder vote scheduled for mid-April.

TZ Limited announces the resignation of CEO David Sampaklis, effective 19 March 2026, with the Board initiating a structured search for new leadership while maintaining strategic focus.

ASX Compliance has formally queried Reckon Limited regarding a late filing of a director interest notice, raising potential breaches of key listing rules. The company must respond swiftly to avoid trading disruptions.

Aldoro Resources has finalised the sale of its Wyemandoo Project to Coppermoly, receiving A$100,000 and redirecting its efforts towards its flagship Kameelburg project.

EBOS Group Limited has updated its interim dividend details for the six months ending December 2025, confirming a fully franked ordinary dividend and a supplementary dividend, alongside a Dividend Reinvestment Plan offering a 2% discount.

The Takeovers Panel has received a formal review application challenging its recent decision on Humm Group Limited, signaling potential further scrutiny of the corporate governance dispute.

EVE Health Group has announced a $1.3 million capital raising through a placement of shares and free attaching options, aimed at advancing its pharmaceutical product rollout and development pipeline. Several components of the offer await shareholder approval at an upcoming general meeting.

Cue Energy Resources has advised shareholders to hold off on any action following Horizon Oil's dispatch of a Replacement Bidder’s Statement for its unsolicited takeover offer. A formal response and recommendation from Cue’s Independent Board Committee is expected by early April.

The Australian Government has increased financial support thresholds for Viva Energy’s Geelong Refinery, reflecting rising operating costs and reinforcing domestic fuel security through the decade.

Ampol has welcomed key amendments to the Fuel Security Services Payment scheme and postponed refinery maintenance to increase domestic fuel production amid global supply disruptions.

AdAlta Limited has been granted a key Canadian patent for its anti-fibrotic drug AD-214, completing its composition of matter protection across all major commercial markets. This milestone strengthens the company’s intellectual property portfolio and underpins its commercial strategy for AD-214.